The FDA has granted de novo clearance to ProciseDx Inc. for its therapeutic drug monitoring tests for Humira and Remicade,…
Browsing: Hot headlines in GI
Alcohol-associated liver disease, one of the most common types of liver disease worldwide, is associated with tremendous morbidity, mortality, and…
A recent study has found that the use of glucagon-like peptide 1 (GLP-1) agonists for weight loss, when compared with…
United Digestive (UD) is pleased to announce that Mark E. Murphy, MD, FACP, AGAF, from Center for Digestive & Liver…
Precede Biosciences, a liquid biopsy company, has come out of stealth mode with a financing of $57 million. The company’s…
The FDA has granted approval to Abrilada, making it the second interchangeable biosimilar to adalimumab. This decision allows Abrilada (adalimumab-afzb,…
Robert Schoen, MD, and Dhiraj Yadav, MD — professors at the University of Pittsburgh School of Medicine — received 2024…
JERUSALEM (Reuters) – Teva Pharmaceutical Industries will collaborate with French drugmaker Sanofi to develop a treatment for inflammatory bowel disease…
The American Gastroenterological Association (AGA) has emphasized the critical need for best practice updates to enhance awareness and treatment of…
GRAIL, LLC, a healthcare company focused on early cancer detection, has unveiled detailed results from its PATHFINDER study on its…